Foster PR - Search Results

1

Distribution of a bovine spongiform encephalopathy-derived agent over ion-exchange chromatography used in the preparation of concentrates of fibrinogen and factor VIII.

Foster PR, Griffin BD, Bienek C, McIntosh RV, MacGregor IR, Somerville RA, Steele PJ, Reichl HE. Foster PR, et al. Vox Sang. 2004 Feb;86(2):92-9. doi: 10.1111/j.0042-9007.2004.00403.x. Vox Sang. 2004. PMID: 15023177

2

Studies on the removal of abnormal prion protein by processes used in the manufacture of human plasma products.

Foster PR, Welch AG, McLean C, Griffin BD, Hardy JC, Bartley A, MacDonald S, Bailey AC. Foster PR, et al. Vox Sang. 2000;78(2):86-95. doi: 10.1159/000031156. Vox Sang. 2000. PMID: 10765143

3

Studies on the removal of a bovine spongiform encephalopathy-derived agent by processes used in the manufacture of human immunoglobulin.

Reichl HE, Foster PR, Welch AG, Li Q, MacGregor IR, Somerville RA, Fernie K, Steele PJ, Taylor DM. Reichl HE, et al. Among authors: foster pr. Vox Sang. 2002 Aug;83(2):137-45. doi: 10.1046/j.1423-0410.2002.00211.x. Vox Sang. 2002. PMID: 12201843

4

The manufacture of factor VIII concentrates.

Foster PR, McIntosh RV. Foster PR, et al. Transfusion. 1991 Jul-Aug;31(6):573-4. doi: 10.1046/j.1537-2995.1991.31691306259.x. Transfusion. 1991. PMID: 1906651 No abstract available.

5

Removal of abnormal prion protein by plasma fractionation.

Foster PR, McLean C, Welch AG, Griffin BD, Hardy JC, Bartley A, MacDonald S, Bailey A. Foster PR, et al. Transfus Sci. 2000 Feb-Apr;22(1-2):53-6. doi: 10.1016/s0955-3886(00)00011-4. Transfus Sci. 2000. PMID: 10771382 No abstract available.

6

Current safety of clotting factor concentrates.

Foster PR, McIntosh RV. Foster PR, et al. Arch Pathol Lab Med. 1990 Dec;114(12):1188-9. Arch Pathol Lab Med. 1990. PMID: 2123621 No abstract available.

7

Hepatitis C and haemophilia.

Foster PR, McIntosh RV, MacLeod AJ. Foster PR, et al. BMJ. 1995 Sep 16;311(7007):754-5. doi: 10.1136/bmj.311.7007.754c. BMJ. 1995. PMID: 7549724 Free PMC article. No abstract available.

8

Removal of TSE agents from blood products.

Foster PR. Foster PR. Vox Sang. 2004 Jul;87 Suppl 2:7-10. doi: 10.1111/j.1741-6892.2004.00444.x. Vox Sang. 2004. PMID: 15209867 Review. No abstract available.

9

Studies on the stability of VIII:C during the manufacture of a factor VIII concentrate for clinical use.

Foster PR, Dickson IH, McQuillan TA, Prowse CV, Boulton FE, Greedharry P, Bloom AL. Foster PR, et al. Vox Sang. 1988;55(2):81-9. doi: 10.1111/j.1423-0410.1988.tb05141.x. Vox Sang. 1988. PMID: 3142152

10

Hepatitis C infection from anti-D immunoglobulin.

Foster PR, McIntosh RV, Welch AG. Foster PR, et al. Lancet. 1995 Aug 5;346(8971):372. Lancet. 1995. PMID: 7623543 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

49 results

Search Page